Antiviral Drugs for Viruses Other Than Human Immunodeficiency Virus

Most viral diseases, with the exception of those caused by human immunodeficiency virus, are self-limited illnesses that do not require specific antiviral therapy. The currently available antiviral drugs target 3 main groups of viruses: herpes, hepatitis, and influenza viruses. With the exception of...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Mayo Clinic proceedings Jg. 86; H. 10; S. 1009 - 1026
1. Verfasser:	Razonable, Raymund R.
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	Rochester, MN Elsevier Inc 01.10.2011 Mayo Foundation Elsevier, Inc Elsevier Limited Mayo Foundation for Medical Education and Research
Schlagworte:	Acyclovir - analogs & derivatives Acyclovir - pharmacology Acyclovir - therapeutic use Adenine - analogs & derivatives Adenine - pharmacology Adenine - therapeutic use Amantadine - pharmacology Antibiotics. Antiinfectious agents. Antiparasitic agents Antiviral agents Antiviral Agents - pharmacology Antiviral Agents - therapeutic use Biological and medical sciences Comorbidity Diagnosis Drug therapy Drug Therapy, Combination Foscarnet - pharmacology Foscarnet - therapeutic use Ganciclovir - analogs & derivatives Ganciclovir - pharmacology Ganciclovir - therapeutic use General aspects Guanine - analogs & derivatives Guanine - pharmacology Guanine - therapeutic use Health aspects Hepatitis - drug therapy Hepatitis B, Chronic - drug therapy Hepatitis C - drug therapy Hepatitis C - epidemiology Herpesviridae Infections - drug therapy HIV infection HIV Infections - drug therapy HIV Infections - epidemiology Human viral diseases Humans Infectious diseases Influenza, Human - drug therapy Interferons - pharmacology Interferons - therapeutic use Internal Medicine Lamivudine - pharmacology Lamivudine - therapeutic use Medical sciences Nucleosides - pharmacology Nucleosides - therapeutic use Oligopeptides - pharmacology Oligopeptides - therapeutic use Organophosphonates - pharmacology Organophosphonates - therapeutic use Oseltamivir - pharmacology Oseltamivir - therapeutic use Pharmacology. Drug treatments Proline - analogs & derivatives Proline - pharmacology Proline - therapeutic use Protease Inhibitors - therapeutic use Pyrimidinones - pharmacology Pyrimidinones - therapeutic use Ribavirin - pharmacology Ribavirin - therapeutic use Symposium on Antimicrobial Therapy Telbivudine Thymidine - analogs & derivatives Valacyclovir Valganciclovir Valine - analogs & derivatives Valine - pharmacology Valine - therapeutic use Viral diseases Viral diseases of the lymphoid tissue and the blood. Aids Virus Replication - drug effects Zanamivir - pharmacology Zanamivir - therapeutic use United States FDA HBeAg ALT HSV mRNA CMV HSV-2 IV SVR SC HSV-1 VZV HIV RSV CSF HHV TK EBV HCV CHB HBV I FN CHC human herpesvirus thymidine kinase hepatitis B virus alanine aminotransferase hepatitis B e antigen herpes simplex virus subcutaneous intravenous cytomegalovirus messenger RNA hepatitis C virus Epstein-Barr virus US Food and Drug Administration sustained virologic response chronic hepatitis B chronic hepatitis C interferon HSV type 2 HSV type 1 cerebrospinal fluid human immunodeficiency virus varicella zoster virus respiratory syncytial virus Infection Virus Medicine Drug Immunopathology Viral disease Retroviridae Antiviral AIDS Human immunodeficiency virus Immune deficiency Lentivirus
ISSN:	0025-6196, 1942-5546, 1942-5546
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!